Cargando…
Development of nanoscale drug delivery systems of dihydroartemisinin for cancer therapy: A review
Dihydroartemisinin (DHA), a first-line antimalarial drug, has demonstrated great anticancer effects in many types of tumors, including liver cancer, glioblastoma, and pancreatic cancer. Due to its abilities to induce programmed cell death (PCD; apoptosis, autophagy and ferroptosis), inhibit tumor me...
Autores principales: | Wong, Ka Hong, Yang, Donglin, Chen, Shanshan, He, Chengwei, Chen, Meiwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459003/ https://www.ncbi.nlm.nih.gov/pubmed/36105316 http://dx.doi.org/10.1016/j.ajps.2022.04.005 |
Ejemplares similares
-
Recent insights into the biological activities and drug delivery systems of tanshinones
por: Cai, Yuee, et al.
Publicado: (2016) -
Nanoscale Drug Delivery Systems in Glioblastoma
por: Liu, Zihao, et al.
Publicado: (2022) -
Oil–water partition coefficient preparation and detection in the dihydroartemisinin self-emulsifying drug delivery system
por: Wang, Yunhong, et al.
Publicado: (2022) -
Elasticity, an often-overseen parameter in the development of nanoscale drug delivery systems
por: Weiss, Agnes-Valencia, et al.
Publicado: (2023) -
Nanoscale drug delivery systems and the blood–brain barrier
por: Alyautdin, Renad, et al.
Publicado: (2014)